Literature DB >> 2431051

Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

C R Bangham, P J Openshaw, L A Ball, A M King, G W Wertz, B A Askonas.   

Abstract

The viral antigens recognized by cytotoxic T cells (CTL) have not been defined in most viruses infecting mouse or man. Natural or artificial virus recombinants can be used to determine the antigen specificity of CTL directed against viruses with segmented genomes, such as influenza, but this technique is more difficult to apply to the study of unsegmented viruses. We describe here the use of recombinant vaccinia viruses, containing cDNA corresponding to either the nucleoprotein (N) gene or the major surface glycoprotein (G) gene of human respiratory syncytial virus (RSV), to examine the antigen specificity of anti-RSV cytotoxic T cells from humans and mice. The results demonstrate that the RSV N protein is one of the target antigens for CTL in man and mouse, whereas the G protein was not recognized and can at best represent a minor target antigen for CTL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.

Authors:  A H Brandenburg; L de Waal; H H Timmerman; P Hoogerhout; R L de Swart; A D Osterhaus
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection.

Authors:  S H Seo; L Wang; R Smith; E W Collisson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Animal models of respiratory syncytial virus infection and disease.

Authors:  Randy E Sacco; Russell K Durbin; Joan E Durbin
Journal:  Curr Opin Virol       Date:  2015-07-11       Impact factor: 7.090

4.  Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan.

Authors:  K Nagai; H Tsutsumi; H Yamazaki; S Pattamadilok; S Chiba
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.

Authors:  R Khanna; C A Jacob; S R Burrows; M G Kurilla; E Kieff; I S Misko; T B Sculley; D J Moss
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

6.  Cell-mediated immune responses of lambs to challenge with bovine respiratory syncytial virus.

Authors:  A K Sharma; Z Woldehiwet
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Authors:  Hoyin Mok; Sujin Lee; David W Wright; James E Crowe
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

8.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice.

Authors:  A M King; E J Stott; S J Langer; K K Young; L A Ball; G W Wertz
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

10.  Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination.

Authors:  Elaine M Castilow; Steven M Varga
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.